| Patents for C07D 473 - Heterocyclic compounds containing purine ring systems (11,932) |
|---|
| 03/17/2010 | CN101674834A inhibitors of bruton's tyrosine kinase |
| 03/17/2010 | CN101671334A Production technology of pamabrom |
| 03/16/2010 | CA2390590C Adenosine receptor antagonists and methods of making and using the same |
| 03/11/2010 | WO2010027326A1 Peptide nucleic acid monomers and oligomers |
| 03/11/2010 | WO2009146542A8 6-(c2-6alkylseleno)purines and methods for treating neural measles viral infection therewith |
| 03/11/2010 | CA2733533A1 Hedgehog pathway modulators |
| 03/04/2010 | US20100056782 reacting compound containing C Cl, C Br or C I bond (chlorobenzene, chlorofluorobenzene)with a hydrogenating agent ( H2) and a heterogeneous hydrogenation catalyst ( Pd/Al2O3) in the presence of an ionic liquid (cationic and anionic) for hydrodehalogenation |
| 03/04/2010 | US20100056538 Pro-drugs of A2B Adenosine Receptor Antagonists |
| 03/04/2010 | US20100056494 Purine compounds and compositions as kinase inhibitors for the treatment of plasmodium related diseases |
| 03/03/2010 | EP2159226A1 Antihistaminic and antiallergic agent and a method for the production thereof. |
| 03/03/2010 | EP2158202A1 New compounds 892 |
| 03/03/2010 | EP0852499B1 Therapeutic azide compounds |
| 03/02/2010 | US7671036 Positively-charged peptide nucleic acid analogs with improved properties |
| 02/25/2010 | WO2010022358A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazoio[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/25/2010 | US20100048890 Conjugated small molecules |
| 02/25/2010 | US20100048600 such as trans-2-[3'-oxospiro [cyclohexane- 1,1'(3'H)-isobenzofuran]-4yl]-5-(2-pyridyl) imidazo[4,5-b]pyridine, exhibiting neuropeptide Y antagonistic effects, used for the treatment of cardiovascular, nervous system, metabolic, gastrointestinal, sexual and respiratory system disorders; pharmacokinetics |
| 02/25/2010 | US20100048590 N-(3-amino-2-hydroxy-propyl) substituted alkylamide compounds |
| 02/25/2010 | CA2735048A1 6-substituted 2-(benzimidazolyl)purine and purinone derivatives and 6-substituted 2-(imidazolo[4,5- c]pyridinyl)purine and purinone derivatives for immunosuppression |
| 02/24/2010 | EP2155771A1 Azido purine nucleosides for treatment of viral infections |
| 02/24/2010 | EP1465631B1 Pyrimidine a2b selective antagonist compounds, their synthesis and use |
| 02/24/2010 | CN101657453A Purines as PKC-theta inhibitors |
| 02/23/2010 | US7667058 Catalytic supports; dehydrohalogenation |
| 02/18/2010 | WO2010018268A1 Novel (rs)-7- or 9-(1,2,3,5-tetrahydro-4,1-benzoxazepin-3-il)-7h or 9h-purines having antitumour activity |
| 02/18/2010 | WO2010018134A1 Novel adenine derivatives |
| 02/18/2010 | WO2010018133A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010018132A1 Compounds |
| 02/18/2010 | WO2010018131A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | WO2010018130A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | US20100041883 Process for the preparation of abacavir |
| 02/18/2010 | US20100041650 Purine compounds as cannabinoid receptor blockers |
| 02/18/2010 | CA2733750A1 Novel adenine derivatives |
| 02/18/2010 | CA2733749A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/18/2010 | CA2733743A1 Purine derivatives for use in the treatment of allergic, inflammatory and infectious diseases |
| 02/17/2010 | EP2152719A1 Bicyclic heteroaromatic compounds as inhibitors of stearoyl-coenzyme a delta-9 desaturase |
| 02/17/2010 | EP2152707A1 [6,5]-bicyclic gpr119 g protein-coupled receptor agonists |
| 02/17/2010 | EP2152705A1 9- (pyrazol- 3 -yl) - 9h- purine-2 -amine and 3- (pyraz0l-3-yl) -3h-imidaz0 [4, 5-b]pyridin-5-amine derivatives and their use for the treatment of cancer |
| 02/17/2010 | EP1551839B1 Process for preparing 9-¬4-acetoxy-3-(acetoxymethyl)but-1-yl -2-aminopurine |
| 02/17/2010 | CN101648951A pentoxifylline derivative |
| 02/17/2010 | CN100590125C Xanthine derivatives as A2B adenosine receptor antagonists |
| 02/16/2010 | US7662938 2′-fluoronucleosides |
| 02/16/2010 | US7662827 Pyrazole derivatives having tyrosine kinase inhibitory activity |
| 02/16/2010 | US7662767 inhibiting complexation of intercalating molecules with polynucleotides; using modified xanthine molecules as a binding agent; drug delivery system for compounds that have low solubility in aqueous media, including anti-neoplastic agents |
| 02/11/2010 | US20100035901 Adenine derivative as inhibitors of hsp90 for the treatment of cancer |
| 02/10/2010 | EP2150115A1 Cyclopropyl pyrrolidine orexin receptor antagonists |
| 02/10/2010 | EP1699800B1 Bicyclic heterocyclic p-38 kinase inhibitors |
| 02/10/2010 | CN101646669A Purinyl derivatives and their use as potassium channel modulators |
| 02/09/2010 | CA2287370C Synthesis, anti-human immunodeficiency virus and anti-hepatitis b virus activities of 1,3-oxaselenolane nucleosides |
| 02/04/2010 | WO2010013466A1 Inhibition of replication of hepatitis c virus by cdk inhibitor |
| 02/04/2010 | US20100029693 Novel pi3k delta inhibitors and methods of use thereof |
| 02/04/2010 | US20100029671 Heterocyclic Compounds And Uses Thereof In The Treatment Of Sexual Disorders |
| 02/04/2010 | CA2732320A1 A3 adenosine receptor antagonists and partial agonists |
| 02/03/2010 | EP2149574A1 2, 6-dinitrogen-containing substituted purine derivatives, the preparation and uses thereof |
| 02/02/2010 | US7655638 Partial and full agonists of A1 adenosine receptors |
| 02/02/2010 | CA2465090C Polymeric thiol-linked prodrugs employing benzyl elimination systems |
| 01/28/2010 | US20100022533 Compositions and methods for inducing cell dedifferentiation |
| 01/27/2010 | CN101632663A Novel molecular target for neurotoxicity |
| 01/26/2010 | CA2465206C Polymeric thiol-linked prodrugs |
| 01/26/2010 | CA2338854C Nitric esters and nitrate salts of specific drugs |
| 01/21/2010 | WO2010009210A2 Acetylsalicyclic acid derivatives useful to treat metabolic syndromes |
| 01/21/2010 | WO2010009207A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/21/2010 | WO2009115927A3 Nucleotide analogues with quaternary carbon stereogenic centers and methods of use |
| 01/21/2010 | US20100016588 Caffeine fraction obtained from tea leaves and a method for inducing agrobacterium tumefaciens-mediated genetic transformation in plants using said caffeine fraction |
| 01/21/2010 | US20100016586 Therapeutic compounds and their use in cancer |
| 01/21/2010 | US20100016578 Macrocyclic serine protease inhibitors |
| 01/21/2010 | US20100016329 Xanthine-based cyclic gmp-enhancing rho-kinase inhibitor inhibits physiological activities of lung epithelial cell line |
| 01/21/2010 | CA2730610A1 Bicyclic heterocycle derivatives and their use as gpcr modulators |
| 01/20/2010 | EP2145888A1 Deazapurine derivatives as HSP90-Inhibitors |
| 01/20/2010 | CN101631788A 8-Alkynylxanthines and Derivatives |
| 01/19/2010 | CA2465928C Synthesis and purification of valacyclovir |
| 01/19/2010 | CA2239904C Inhibitors of interleukin-1.beta. converting enzyme |
| 01/14/2010 | WO2010005558A2 Pi3k isoform selective inhibitors |
| 01/14/2010 | US20100011306 Data-driven layout engine |
| 01/14/2010 | US20100010217 Methods for the preparation of imidazole-containing compounds |
| 01/14/2010 | US20100010021 Novel compounds |
| 01/14/2010 | US20100010020 Phosphodiesterase 4 inhibitors |
| 01/14/2010 | US20100008866 Cis-cyclohexyl substituted pyrimidinone derivatives |
| 01/14/2010 | CA2730271A1 Pi3k isoform selective inhibitors |
| 01/14/2010 | CA2727282A1 Novel pyrrolidine derivatives as metap-2 inhibitors |
| 01/13/2010 | EP2143724A1 Nitrogenated fused ring derivative, pharmaceutical composition comprising the same, and use of the same for medical purposes |
| 01/13/2010 | EP2142549A1 Adenosine derivatives, method for the synthesis thereof, and the pharmaceutical compositions for the prevention and treatment of the inflammatory diseases containing the same as an active ingredient |
| 01/13/2010 | EP2142548A1 Novel derivatives of purinic and pyrimidinic antiviral agents and use thereof as potent anticancer agents |
| 01/13/2010 | CN101627040A Fused pyrimidinone compounds as mGluR ligands |
| 01/13/2010 | CN100579518C Use of EP4 receptor ligands in the treatment of IL-6 involved diseases |
| 01/12/2010 | US7645763 dipeptidylpeptidase-IV inhibitors; antidiabetic agents, antiarthritic agents, obesity, allograft transplantation, and osteoporosis caused by calcitonin; 1,3-disubstituted-7-(2-butyn-1-yl)-8-(3-aminopiperidin-1-yl)-xanthine compounds |
| 01/12/2010 | CA2411418C Hydroxyformamidine derivatives and medicines containing the same |
| 01/12/2010 | CA2403514C 8-quinolinxanthine and 8-isoquinolinxanthine derivatives as pde 5 inhibitors |
| 01/12/2010 | CA2399062C Stereoselective synthesis of nucleoside analogues |
| 01/07/2010 | WO2010000429A1 Adenine receptor ligands |
| 01/07/2010 | WO2009131687A3 Inhibitors of protein kinases |
| 01/07/2010 | WO2009068761A3 Use of purine derivatives for the manufacture of a medicament |
| 01/07/2010 | US20100004446 Process for the Preparation of Abacavir |
| 01/07/2010 | US20100004445 Methods for the synthesis of unsymmetrical cycloalkyl substituted xanthines |
| 01/07/2010 | US20100004440 Novel acyclic nucleoside phosphonate derivatives, salts thereof and process for the preparation of the same |
| 01/07/2010 | US20100004236 Phosphodiesterase 4 inhibitors |
| 01/07/2010 | US20100003188 Method for intercalating chromophores into zeolite-l nanochannels and products thereof |
| 01/07/2010 | CA2728681A1 Adenine receptor ligands |
| 01/06/2010 | EP2141166A1 Adenine receptor ligands |
| 01/06/2010 | EP2139894A1 9-substituted-8-oxo-adenine compounds as toll-like receptor (tlr7) modulators |
| 01/05/2010 | US7642350 Purine derivatives |
| 01/05/2010 | US7642267 Benzimidazole and pyridylimidazole derivatives |